Header Logo

Connection

NICOLA HANANIA to Humans

Back to Details
This is a "connection" page, showing publications NICOLA HANANIA has written about Humans.
NICOLA HANANIA
Connection Strength
2.494
Humans
  1. POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes. Chest. 2024 Jul; 166(1):12-17.
    View in: PubMed
    Score: 0.025
  2. Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation. Respir Med. 2024 06; 227:107633.
    View in: PubMed
    Score: 0.025
  3. Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza Other Respir Viruses. 2023 12; 17(12):e13231.
    View in: PubMed
    Score: 0.025
  4. Influence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab. J Allergy Clin Immunol Pract. 2024 02; 12(2):512-514.e2.
    View in: PubMed
    Score: 0.025
  5. Adding tiotropium or long-acting ?2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization. Allergy Asthma Proc. 2023 11 13; 44(6):413-421.
    View in: PubMed
    Score: 0.024
  6. Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer? Am J Respir Crit Care Med. 2023 09 01; 208(5):509-511.
    View in: PubMed
    Score: 0.024
  7. Integrating innovations in asthma research into clinical practice. Respir Med. 2023 10; 217:107345.
    View in: PubMed
    Score: 0.024
  8. COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. Int J Chron Obstruct Pulmon Dis. 2023; 18:407-418.
    View in: PubMed
    Score: 0.023
  9. Asthma and cardiovascular disease: A bidirectional association? Respirology. 2023 03; 28(3):217-219.
    View in: PubMed
    Score: 0.023
  10. Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications. Kardiol Pol. 2023; 81(3):232-241.
    View in: PubMed
    Score: 0.023
  11. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review. Mayo Clin Proc. 2023 02; 98(2):301-315.
    View in: PubMed
    Score: 0.023
  12. Is Extracorporeal Membrane Oxygenation More Than Just Salvage Therapy in Acute Life-Threatening Asthma? Chest. 2023 01; 163(1):1-2.
    View in: PubMed
    Score: 0.023
  13. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction. Ann Allergy Asthma Immunol. 2023 02; 130(2):206-214.e2.
    View in: PubMed
    Score: 0.023
  14. Choosing and switching biological agents in severe asthma. Respirology. 2022 11; 27(11):926-928.
    View in: PubMed
    Score: 0.023
  15. When Asthma and Chronic Obstructive Pulmonary Disease Overlap; Current Knowledge and Unmet Needs. Immunol Allergy Clin North Am. 2022 08; 42(3):499-505.
    View in: PubMed
    Score: 0.022
  16. Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):657-669.
    View in: PubMed
    Score: 0.022
  17. Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):645-655.
    View in: PubMed
    Score: 0.022
  18. Asthma-Chronic Obstructive Pulmonary Disease: An Update. Immunol Allergy Clin North Am. 2022 08; 42(3):xiii-xiv.
    View in: PubMed
    Score: 0.022
  19. The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety. Respir Med. 2022 06; 197:106850.
    View in: PubMed
    Score: 0.022
  20. Management of Life-Threatening Asthma: Severe Asthma Series. Chest. 2022 10; 162(4):747-756.
    View in: PubMed
    Score: 0.022
  21. Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med. 2022 03; 193:106742.
    View in: PubMed
    Score: 0.022
  22. Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgrad Med. 2022 Mar; 134(2):152-159.
    View in: PubMed
    Score: 0.021
  23. Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home. Int J Chron Obstruct Pulmon Dis. 2021; 16:2687-2695.
    View in: PubMed
    Score: 0.021
  24. Revisiting Mild Asthma: Current Knowledge and Future Needs. Chest. 2022 01; 161(1):26-39.
    View in: PubMed
    Score: 0.021
  25. Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA. J Allergy Clin Immunol Pract. 2022 01; 10(1):222-228.
    View in: PubMed
    Score: 0.021
  26. Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials. Int J Chron Obstruct Pulmon Dis. 2021; 16:1925-1938.
    View in: PubMed
    Score: 0.021
  27. Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study. Chest. 2021 09; 160(3):1026-1034.
    View in: PubMed
    Score: 0.020
  28. Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies. Int J Chron Obstruct Pulmon Dis. 2021; 16:865-875.
    View in: PubMed
    Score: 0.020
  29. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps. Curr Opin Pulm Med. 2021 01; 27(1):45-53.
    View in: PubMed
    Score: 0.020
  30. Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. Expert Rev Respir Med. 2021 01; 15(1):153-159.
    View in: PubMed
    Score: 0.020
  31. Long-Term Benefits of Pulmonary Rehabilitation in Patients With COPD: A 2-Year Follow-Up Study. Chest. 2021 03; 159(3):967-974.
    View in: PubMed
    Score: 0.020
  32. Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial. Chest. 2021 03; 159(3):985-995.
    View in: PubMed
    Score: 0.020
  33. Determinants of lung function improvement with omalizumab in adults with allergic asthma. J Allergy Clin Immunol Pract. 2020 06; 8(6):2068-2070.
    View in: PubMed
    Score: 0.019
  34. Response. Chest. 2019 12; 156(6):1276.
    View in: PubMed
    Score: 0.019
  35. Immunological biomarkers in severe asthma. Semin Immunol. 2019 12; 46:101332.
    View in: PubMed
    Score: 0.018
  36. Biological treatments for severe asthma. Curr Opin Allergy Clin Immunol. 2019 08; 19(4):379-386.
    View in: PubMed
    Score: 0.018
  37. Management of asthma COPD overlap. Ann Allergy Asthma Immunol. 2019 10; 123(4):335-344.
    View in: PubMed
    Score: 0.018
  38. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis. 2019; 14:1127-1138.
    View in: PubMed
    Score: 0.018
  39. Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1430-1436.
    View in: PubMed
    Score: 0.018
  40. Targeting lipid mediators in asthma: time for reappraisal. Curr Opin Pulm Med. 2019 01; 25(1):121-127.
    View in: PubMed
    Score: 0.017
  41. The many faces of asthma-chronic obstructive pulmonary disease overlap. Curr Opin Pulm Med. 2019 01; 25(1):1-10.
    View in: PubMed
    Score: 0.017
  42. Validity and Responsiveness of the?Depression Anxiety Stress Scales-21?(DASS-21) in?COPD. Chest. 2019 06; 155(6):1166-1177.
    View in: PubMed
    Score: 0.017
  43. Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:117-127.
    View in: PubMed
    Score: 0.017
  44. Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO. J Allergy Clin Immunol. 2019 04; 143(4):1629-1633.e2.
    View in: PubMed
    Score: 0.017
  45. COPD Management in the Primary Care Setting. J Fam Pract. 2018 10; 67(10 Suppl):S27-S32.
    View in: PubMed
    Score: 0.017
  46. Asthma COPD overlap: Impact of associated comorbidities. Pulm Pharmacol Ther. 2018 10; 52:27-31.
    View in: PubMed
    Score: 0.017
  47. Measurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions. Ann Allergy Asthma Immunol. 2018 04; 120(4):414-418.e1.
    View in: PubMed
    Score: 0.017
  48. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. Int J Chron Obstruct Pulmon Dis. 2018; 13:499-508.
    View in: PubMed
    Score: 0.016
  49. COPD in Primary Care: Key Considerations for Optimized Management: Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. J Fam Pract. 2018 02; 67(2 Suppl):S11-S18.
    View in: PubMed
    Score: 0.016
  50. Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. Cleve Clin J Med. 2018 Feb; 85(2 Suppl 1):S11-S18.
    View in: PubMed
    Score: 0.016
  51. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts. J Am Med Dir Assoc. 2017 Dec 01; 18(12):1063-1068.
    View in: PubMed
    Score: 0.016
  52. Procalcitonin in Chronic Obstructive Pulmonary Disease Exacerbations: Is It Ready for Primetime Use? Ann Am Thorac Soc. 2017 12; 14(12):1757-1758.
    View in: PubMed
    Score: 0.016
  53. Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma. Allergy. 2018 02; 73(2):490-497.
    View in: PubMed
    Score: 0.016
  54. Predictive Biomarkers for Asthma Therapy. Curr Allergy Asthma Rep. 2017 Sep 19; 17(10):69.
    View in: PubMed
    Score: 0.016
  55. Factors associated with depressive symptoms in uncontrolled asthmatics. J Asthma. 2018 05; 55(5):555-560.
    View in: PubMed
    Score: 0.016
  56. Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD. Expert Opin Emerg Drugs. 2017 09; 22(3):285-299.
    View in: PubMed
    Score: 0.016
  57. Effect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial. J Altern Complement Med. 2017 Sep; 23(9):696-704.
    View in: PubMed
    Score: 0.016
  58. Assessing Patient and Provider Perceptions of Factors Associated with Patient Engagement in Asthma Care. Ann Am Thorac Soc. 2017 May; 14(5):659-666.
    View in: PubMed
    Score: 0.016
  59. Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgrad Med. 2017 Jun; 129(5):500-512.
    View in: PubMed
    Score: 0.015
  60. Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension? Delivery Technology in patients with chronic obstructive pulmonary disease. Respir Med. 2017 05; 126:105-115.
    View in: PubMed
    Score: 0.015
  61. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017 Feb; 47(2):161-175.
    View in: PubMed
    Score: 0.015
  62. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2016 10; 4(10):781-796.
    View in: PubMed
    Score: 0.015
  63. Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. Expert Rev Respir Med. 2016 07; 10(7):767-80.
    View in: PubMed
    Score: 0.015
  64. The Responsiveness of the Anxiety Inventory for Respiratory Disease Scale Following Pulmonary Rehabilitation. Chest. 2016 07; 150(1):188-95.
    View in: PubMed
    Score: 0.014
  65. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015 Aug; 70(8):748-56.
    View in: PubMed
    Score: 0.014
  66. Hospital management of acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med. 2015 May; 10(5):328-39.
    View in: PubMed
    Score: 0.013
  67. The asthma COPD overlap syndrome (ACOS). Curr Allergy Asthma Rep. 2015 Mar; 15(3):509.
    View in: PubMed
    Score: 0.013
  68. Role of anticholinergics in asthma management: recent evidence and future needs. Curr Opin Pulm Med. 2015 Jan; 21(1):103-8.
    View in: PubMed
    Score: 0.013
  69. Periostin, a novel biomarker of TH2-driven asthma. Curr Opin Pulm Med. 2014 Jan; 20(1):60-5.
    View in: PubMed
    Score: 0.012
  70. Evaluating the safety of COPD medications: an evidence-based review. Chest. 2013 Oct; 144(4):1357-1367.
    View in: PubMed
    Score: 0.012
  71. Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD. Respir Med. 2014 Feb; 108(2):366-75.
    View in: PubMed
    Score: 0.012
  72. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013 Apr 15; 187(8):804-11.
    View in: PubMed
    Score: 0.012
  73. Ten years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis. 2013; 8:117-25.
    View in: PubMed
    Score: 0.012
  74. Asthma outcomes revisited. Curr Opin Pulm Med. 2013 Jan; 19(1):6-12.
    View in: PubMed
    Score: 0.011
  75. Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Respir Med. 2012 Dec; 106 Suppl 2:S1-2.
    View in: PubMed
    Score: 0.011
  76. Effect of a primary care continuing education program on clinical practice of chronic obstructive pulmonary disease: translating theory into practice. Mayo Clin Proc. 2012 Sep; 87(9):862-70.
    View in: PubMed
    Score: 0.011
  77. The efficacy and safety of the novel long-acting ?2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial. Chest. 2012 Jul; 142(1):119-127.
    View in: PubMed
    Score: 0.011
  78. New bronchodilators. Curr Opin Pharmacol. 2012 Jun; 12(3):238-45.
    View in: PubMed
    Score: 0.011
  79. Targeting IgE in asthma. Curr Opin Pulm Med. 2012 Jan; 18(1):1-5.
    View in: PubMed
    Score: 0.011
  80. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med. 2012 Mar; 106(3):319-28.
    View in: PubMed
    Score: 0.011
  81. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. Respir Med. 2012 Jan; 106(1):91-101.
    View in: PubMed
    Score: 0.011
  82. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med. 2011 Oct; 105(10):1516-22.
    View in: PubMed
    Score: 0.011
  83. Bronchodilator reversibility in COPD. Chest. 2011 Oct; 140(4):1055-1063.
    View in: PubMed
    Score: 0.011
  84. The COPD Pipeline XII. COPD. 2011 Oct; 8(5):387-91.
    View in: PubMed
    Score: 0.010
  85. Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011 Sep; 128(3 Suppl):S4-24.
    View in: PubMed
    Score: 0.010
  86. A unified front against COPD: clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society. Chest. 2011 Sep; 140(3):565-566.
    View in: PubMed
    Score: 0.010
  87. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011 Aug; 8(4):293-9.
    View in: PubMed
    Score: 0.010
  88. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Ann Intern Med. 2011 05 03; 154(9):573-82.
    View in: PubMed
    Score: 0.010
  89. Safety of chronic obstructive pulmonary disease medications: a primary care perspective. Postgrad Med. 2011 May; 123(3):72-9.
    View in: PubMed
    Score: 0.010
  90. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6.
    View in: PubMed
    Score: 0.010
  91. Vitamin D and asthma. Curr Opin Pulm Med. 2011 Jan; 17(1):1-5.
    View in: PubMed
    Score: 0.010
  92. COPD in the elderly patient. Semin Respir Crit Care Med. 2010 Oct; 31(5):596-606.
    View in: PubMed
    Score: 0.010
  93. Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010 Oct 05; 5:357-66.
    View in: PubMed
    Score: 0.010
  94. Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J. 2010 Oct; 36(4):963-5.
    View in: PubMed
    Score: 0.010
  95. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):604-11.
    View in: PubMed
    Score: 0.010
  96. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 May 06; 5:125-32.
    View in: PubMed
    Score: 0.010
  97. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med. 2010 Aug; 104(8):1160-70.
    View in: PubMed
    Score: 0.009
  98. The safety and efficacy of arformoterol and formoterol in COPD. COPD. 2010 Feb; 7(1):17-31.
    View in: PubMed
    Score: 0.009
  99. Asthma in the elderly: current knowledge and future directions. Curr Opin Pulm Med. 2010 Jan; 16(1):55-9.
    View in: PubMed
    Score: 0.009
  100. Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med. 2010 Jan; 16(1):1-5.
    View in: PubMed
    Score: 0.009
  101. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Drugs. 2009 Jun 18; 69(9):1205-16.
    View in: PubMed
    Score: 0.009
  102. Asthma control: a new perspective on the management of asthma. Curr Opin Pulm Med. 2009 Jan; 15(1):1-3.
    View in: PubMed
    Score: 0.009
  103. Evaluation of obstructive lung disease with vibration response imaging. J Asthma. 2008 Dec; 45(10):923-30.
    View in: PubMed
    Score: 0.009
  104. Targeting airway inflammation in asthma: current and future therapies. Chest. 2008 Apr; 133(4):989-98.
    View in: PubMed
    Score: 0.008
  105. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm Pharmacol Ther. 2008; 21(3):540-50.
    View in: PubMed
    Score: 0.008
  106. Asthma in older adults. Clin Chest Med. 2007 Dec; 28(4):685-702, v.
    View in: PubMed
    Score: 0.008
  107. The potential role of natural agents in treatment of airway inflammation. Ther Adv Respir Dis. 2007 Dec; 1(2):105-20.
    View in: PubMed
    Score: 0.008
  108. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc Am Thorac Soc. 2007 Oct 01; 4(7):526-34.
    View in: PubMed
    Score: 0.008
  109. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Clin Ther. 2007 Oct; 29(10):2121-33.
    View in: PubMed
    Score: 0.008
  110. Update on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007 Sep; 28(3):589-607, vi-vii.
    View in: PubMed
    Score: 0.008
  111. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008; 21(1):134-41.
    View in: PubMed
    Score: 0.008
  112. One hundred years of chronic obstructive pulmonary disease (COPD). Respir Med. 2007 Jun; 101(6):1049-65.
    View in: PubMed
    Score: 0.008
  113. Can we predict depression in COPD? COPD. 2007 Mar; 4(1):3-4.
    View in: PubMed
    Score: 0.008
  114. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma. Respir Med. 2007 May; 101(5):1007-14.
    View in: PubMed
    Score: 0.007
  115. Revisiting asthma control: how should it best be defined? Pulm Pharmacol Ther. 2007; 20(5):483-92.
    View in: PubMed
    Score: 0.007
  116. Influenza vaccine in patients with asthma. Expert Rev Vaccines. 2006 Feb; 5(1):111-8.
    View in: PubMed
    Score: 0.007
  117. The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2006; 1(4):345-54.
    View in: PubMed
    Score: 0.007
  118. Treatments for COPD. Respir Med. 2005 Dec; 99 Suppl B:S28-40.
    View in: PubMed
    Score: 0.007
  119. Acute asthma in pregnancy. Crit Care Med. 2005 Oct; 33(10 Suppl):S319-24.
    View in: PubMed
    Score: 0.007
  120. The challenge of differentiating asthma from chronic obstructive pulmonary disease. Manag Care. 2005 Jul; 14(7 Suppl Obstructie Lung):9-15; discussion 24-6.
    View in: PubMed
    Score: 0.007
  121. Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease. Curr Opin Pulm Med. 2005 Mar; 11(2):129-34.
    View in: PubMed
    Score: 0.007
  122. The Direct and Indirect Role of IgE on Airway Epithelium in Asthma. Allergy. 2025 Apr; 80(4):919-931.
    View in: PubMed
    Score: 0.007
  123. Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2025 Mar; 13(3):234-243.
    View in: PubMed
    Score: 0.007
  124. The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD. Pulm Pharmacol Ther. 2005; 18(1):19-22.
    View in: PubMed
    Score: 0.007
  125. Association of Insulin Resistance With Radiographic Lung Abnormalities and Incident Lung Disease: The Framingham Offspring Study. Diabetes Care. 2025 Jan 01; 48(1):143-148.
    View in: PubMed
    Score: 0.007
  126. Promoting Prevention and Targeting Remission of Asthma: A EUFOREA Consensus Statement on Raising the Bar in Asthma Care. Chest. 2025 Apr; 167(4):956-974.
    View in: PubMed
    Score: 0.007
  127. Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS). Respir Med. 2025 Jan; 236:107846.
    View in: PubMed
    Score: 0.007
  128. Acute asthma in pregnancy. Crit Care Clin. 2004 Oct; 20(4):731-45, x.
    View in: PubMed
    Score: 0.006
  129. Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences. Drugs. 2024 Oct; 84(10):1251-1273.
    View in: PubMed
    Score: 0.006
  130. Anti-inflammatory activities of beta2-agonists. Curr Drug Targets Inflamm Allergy. 2004 Sep; 3(3):271-7.
    View in: PubMed
    Score: 0.006
  131. Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2372-2380.e5.
    View in: PubMed
    Score: 0.006
  132. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. N Engl J Med. 2024 06 27; 390(24):2274-2283.
    View in: PubMed
    Score: 0.006
  133. Identification of sleep phenotypes in COPD using machine learning-based cluster analysis. Respir Med. 2024 06; 227:107641.
    View in: PubMed
    Score: 0.006
  134. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004 Apr; 113(4):717-24.
    View in: PubMed
    Score: 0.006
  135. An Update on Patient-Reported Outcomes in Asthma. Chest. 2024 May; 165(5):1049-1057.
    View in: PubMed
    Score: 0.006
  136. Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population. J Allergy Clin Immunol Pract. 2024 May; 12(5):1215-1224.e3.
    View in: PubMed
    Score: 0.006
  137. Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020-2023. Lung. 2024 04; 202(2):119-125.
    View in: PubMed
    Score: 0.006
  138. Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma. Respir Med. 2024 03; 223:107537.
    View in: PubMed
    Score: 0.006
  139. Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations. Am J Respir Crit Care Med. 2024 01 01; 209(1):59-69.
    View in: PubMed
    Score: 0.006
  140. Tezepelumab in patients with allergic and eosinophilic asthma. Allergy. 2024 05; 79(5):1134-1145.
    View in: PubMed
    Score: 0.006
  141. Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient. Respir Med. 2023 11; 218:107414.
    View in: PubMed
    Score: 0.006
  142. Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization. Clin Exp Allergy. 2023 10; 53(10):1020-1030.
    View in: PubMed
    Score: 0.006
  143. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest. 2003 Sep; 124(3):834-43.
    View in: PubMed
    Score: 0.006
  144. Revisiting asthma pharmacotherapy: where do we stand and where do we want to go? Eur Respir J. 2023 08; 62(2).
    View in: PubMed
    Score: 0.006
  145. An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials. Am J Respir Crit Care Med. 2023 08 15; 208(4):374-394.
    View in: PubMed
    Score: 0.006
  146. Asthma in the era of COVID-19. Respir Med. 2023 11; 218:107373.
    View in: PubMed
    Score: 0.006
  147. EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients. Respir Med. 2023 11; 218:107361.
    View in: PubMed
    Score: 0.006
  148. Novel Anti-Inflammatory Approaches to COPD. Int J Chron Obstruct Pulmon Dis. 2023; 18:1333-1352.
    View in: PubMed
    Score: 0.006
  149. Clinic vs?Home Spirometry for Monitoring Lung Function in Patients With Asthma. Chest. 2023 11; 164(5):1087-1096.
    View in: PubMed
    Score: 0.006
  150. Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities. Drugs Aging. 2023 07; 40(7):605-619.
    View in: PubMed
    Score: 0.006
  151. Questions in Mild Asthma: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 06 01; 207(11):e77-e96.
    View in: PubMed
    Score: 0.006
  152. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med. 2023 Jul 20; 389(3):205-214.
    View in: PubMed
    Score: 0.006
  153. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clin Sci (Lond). 2023 05 18; 137(9):727-753.
    View in: PubMed
    Score: 0.006
  154. Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study. J Gen Intern Med. 2023 10; 38(13):2988-2997.
    View in: PubMed
    Score: 0.006
  155. Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease. Respir Med. 2023 03; 208:107126.
    View in: PubMed
    Score: 0.006
  156. Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma. J Allergy Clin Immunol Pract. 2023 03; 11(3):873-884.e11.
    View in: PubMed
    Score: 0.006
  157. COPD: Providing the right treatment for the right patient at the right time. Respir Med. 2023 02; 207:107041.
    View in: PubMed
    Score: 0.006
  158. Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. Respir Med. 2022 12; 205:107040.
    View in: PubMed
    Score: 0.006
  159. Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 04; 71(44):1412-1417.
    View in: PubMed
    Score: 0.006
  160. Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With?Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort. Chest. 2023 02; 163(2):292-302.
    View in: PubMed
    Score: 0.006
  161. Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med. 2002 May 15; 165(10):1353-8.
    View in: PubMed
    Score: 0.005
  162. Depressive and anxiety symptoms in patients with COPD: A network analysis. Respir Med. 2022 07; 198:106865.
    View in: PubMed
    Score: 0.005
  163. Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose. J Allergy Clin Immunol Pract. 2022 07; 10(7):1835-1843.
    View in: PubMed
    Score: 0.005
  164. Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans. Nicotine Tob Res. 2022 03 26; 24(5):785-793.
    View in: PubMed
    Score: 0.005
  165. Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma. Chest. 2022 08; 162(2):297-308.
    View in: PubMed
    Score: 0.005
  166. Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts. Ann Am Thorac Soc. 2022 01; 19(1):143-146.
    View in: PubMed
    Score: 0.005
  167. Impact of influenza infection on the short- and long-term health of patients with chronic obstructive pulmonary disease. J Med Econ. 2022 Jan-Dec; 25(1):930-939.
    View in: PubMed
    Score: 0.005
  168. Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2022 02; 10(2):410-419.
    View in: PubMed
    Score: 0.005
  169. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021 11; 47(11):1258-1270.
    View in: PubMed
    Score: 0.005
  170. Association of Systemic Inflammation with Depressive Symptoms in Individuals with COPD. Int J Chron Obstruct Pulmon Dis. 2021; 16:2515-2522.
    View in: PubMed
    Score: 0.005
  171. How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit. J Allergy Clin Immunol Pract. 2021 03; 9(3):1081-1088.
    View in: PubMed
    Score: 0.005
  172. The impact of fungal allergic sensitization on asthma. Curr Opin Pulm Med. 2021 01; 27(1):3-8.
    View in: PubMed
    Score: 0.005
  173. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet Respir Med. 2021 01; 9(1):69-84.
    View in: PubMed
    Score: 0.005
  174. EAACI Biologicals Guidelines-Recommendations for severe asthma. Allergy. 2021 01; 76(1):14-44.
    View in: PubMed
    Score: 0.005
  175. Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST). J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3474-3481.
    View in: PubMed
    Score: 0.005
  176. Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment. Thorax. 2020 09; 75(9):735-743.
    View in: PubMed
    Score: 0.005
  177. Bayesian inference of networks across multiple sample groups and data types. Biostatistics. 2020 07 01; 21(3):561-576.
    View in: PubMed
    Score: 0.005
  178. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2020 11; 125(5):565-576.e1.
    View in: PubMed
    Score: 0.005
  179. Reducing the hidden burden of severe asthma: recognition and referrals from primary practice. J Asthma. 2021 07; 58(7):849-854.
    View in: PubMed
    Score: 0.005
  180. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1043-1057.
    View in: PubMed
    Score: 0.005
  181. Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2020 09; 8(8):2630-2639.e6.
    View in: PubMed
    Score: 0.005
  182. Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge. Eur Respir J. 2020 04; 55(4).
    View in: PubMed
    Score: 0.005
  183. The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015. Ann Am Thorac Soc. 2020 04; 17(4):450-456.
    View in: PubMed
    Score: 0.005
  184. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1058-1068.
    View in: PubMed
    Score: 0.005
  185. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020 06; 75(6):935-945.
    View in: PubMed
    Score: 0.005
  186. Design of a home-based intervention for Houston-area African-American adults with asthma: Methods and lessons learned from a pragmatic randomized trial. Contemp Clin Trials. 2020 04; 91:105977.
    View in: PubMed
    Score: 0.005
  187. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1023-1042.
    View in: PubMed
    Score: 0.005
  188. Precision medicine and treatable traits in chronic airway diseases - where do we stand? Curr Opin Pulm Med. 2020 01; 26(1):33-39.
    View in: PubMed
    Score: 0.005
  189. Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):516-526.
    View in: PubMed
    Score: 0.005
  190. Omalizumab Treatment Patterns Among Patients with Asthma in the US Medicare Population. J Allergy Clin Immunol Pract. 2020 02; 8(2):507-515.e10.
    View in: PubMed
    Score: 0.005
  191. Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients. Respir Med. 2019 Jul - Aug; 154:86-92.
    View in: PubMed
    Score: 0.004
  192. Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study. Chest. 2019 08; 156(2):228-238.
    View in: PubMed
    Score: 0.004
  193. Radiation-Induced Lung Injury: Assessment and Management. Chest. 2019 07; 156(1):150-162.
    View in: PubMed
    Score: 0.004
  194. Accidental hypothermia. Crit Care Clin. 1999 Apr; 15(2):235-49.
    View in: PubMed
    Score: 0.004
  195. Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort. J Psychosom Res. 2019 03; 118:18-26.
    View in: PubMed
    Score: 0.004
  196. Acute respiratory distress syndrome. Inhaled nitric oxide. Respir Care Clin N Am. 1998 Dec; 4(4):695-709.
    View in: PubMed
    Score: 0.004
  197. Vasodilators in mechanical ventilation. Crit Care Clin. 1998 Oct; 14(4):611-27.
    View in: PubMed
    Score: 0.004
  198. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2). Pulm Pharmacol Ther. 2018 Dec; 53:20-26.
    View in: PubMed
    Score: 0.004
  199. New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. Int J Chron Obstruct Pulmon Dis. 2018; 13:2805-2819.
    View in: PubMed
    Score: 0.004
  200. Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients. Chest. 1998 Sep; 114(3):752-6.
    View in: PubMed
    Score: 0.004
  201. Clinical Approach to the Therapy of Asthma-COPD Overlap. Chest. 2019 01; 155(1):168-177.
    View in: PubMed
    Score: 0.004
  202. Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review. Drug Saf. 2018 05; 41(5):489-509.
    View in: PubMed
    Score: 0.004
  203. Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD. Respir Care. 2018 07; 63(7):840-848.
    View in: PubMed
    Score: 0.004
  204. Results of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices. Respir Care. 2018 07; 63(7):833-839.
    View in: PubMed
    Score: 0.004
  205. How does race/ethnicity influence pharmacological response to asthma therapies? Expert Opin Drug Metab Toxicol. 2018 Apr; 14(4):435-446.
    View in: PubMed
    Score: 0.004
  206. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med. 2018 01; 24(1):50-55.
    View in: PubMed
    Score: 0.004
  207. Controversies and opportunities in severe asthma. Curr Opin Pulm Med. 2018 01; 24(1):83-93.
    View in: PubMed
    Score: 0.004
  208. Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017 12; 50(6).
    View in: PubMed
    Score: 0.004
  209. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):633-643.e1.
    View in: PubMed
    Score: 0.004
  210. Obesity modulates diaphragm curvature in subjects with and without COPD. Am J Physiol Regul Integr Comp Physiol. 2017 Nov 01; 313(5):R620-R629.
    View in: PubMed
    Score: 0.004
  211. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. COPD. 2017 Oct; 14(5):552-563.
    View in: PubMed
    Score: 0.004
  212. Trends in 30-day readmission rates after COPD hospitalization, 2006-2012. Respir Med. 2017 Sep; 130:92-97.
    View in: PubMed
    Score: 0.004
  213. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort. J Am Med Dir Assoc. 2017 Nov 01; 18(11):955-959.e6.
    View in: PubMed
    Score: 0.004
  214. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler. J Aerosol Med Pulm Drug Deliv. 2017 Aug; 30(4):256-266.
    View in: PubMed
    Score: 0.004
  215. Factors associated with emergency department dependence of patients with asthma. Chest. 1997 Feb; 111(2):290-5.
    View in: PubMed
    Score: 0.004
  216. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017 02 01; 195(3):324-330.
    View in: PubMed
    Score: 0.004
  217. Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far? Curr Opin Pulm Med. 2017 01; 23(1):3-11.
    View in: PubMed
    Score: 0.004
  218. Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1025-1031.e2.
    View in: PubMed
    Score: 0.004
  219. An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly. Ann Am Thorac Soc. 2016 11; 13(11):2064-2077.
    View in: PubMed
    Score: 0.004
  220. Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD. Chest. 2017 Jan; 151(1):68-77.
    View in: PubMed
    Score: 0.004
  221. Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet. 2016 Aug; 12(8):e1006011.
    View in: PubMed
    Score: 0.004
  222. Characteristics and outcomes of older adults with long-standing versus late-onset asthma. J Asthma. 2017 04; 54(3):223-229.
    View in: PubMed
    Score: 0.004
  223. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 07; 13(7):1016-25.
    View in: PubMed
    Score: 0.004
  224. Assessing biomarkers in a real-world severe asthma study (ARIETTA). Respir Med. 2016 06; 115:7-12.
    View in: PubMed
    Score: 0.004
  225. Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort. Chest. 2016 Apr; 149(4):916-26.
    View in: PubMed
    Score: 0.004
  226. Role of T2 inflammation biomarkers in severe asthma. Curr Opin Pulm Med. 2016 Jan; 22(1):59-68.
    View in: PubMed
    Score: 0.004
  227. Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. Chest. 2016 Apr; 149(4):927-35.
    View in: PubMed
    Score: 0.004
  228. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease. Respir Med. 2016 Feb; 111:30-8.
    View in: PubMed
    Score: 0.004
  229. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995 Nov; 96(5 Pt 1):571-9.
    View in: PubMed
    Score: 0.003
  230. Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup. Ann Am Thorac Soc. 2015 Nov; 12(11):1700-10.
    View in: PubMed
    Score: 0.003
  231. IgE-mediated asthma: New revelations and future insights. Respir Med. 2016 Mar; 112:128-9.
    View in: PubMed
    Score: 0.003
  232. Health-care utilization after near-fatal asthma. Chest. 1995 Jun; 107(6):1564-9.
    View in: PubMed
    Score: 0.003
  233. A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis. 2015; 10:725-38.
    View in: PubMed
    Score: 0.003
  234. Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015 Apr; 147(4):883-893.
    View in: PubMed
    Score: 0.003
  235. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015 Apr; 147(4):894-942.
    View in: PubMed
    Score: 0.003
  236. Adverse effects of inhaled corticosteroids. Am J Med. 1995 Feb; 98(2):196-208.
    View in: PubMed
    Score: 0.003
  237. Antifungals in severe asthma. Curr Opin Pulm Med. 2015 Jan; 21(1):48-54.
    View in: PubMed
    Score: 0.003
  238. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc. 2015 Jan; 12(1):27-34.
    View in: PubMed
    Score: 0.003
  239. A simplified score to quantify comorbidity in COPD. PLoS One. 2014; 9(12):e114438.
    View in: PubMed
    Score: 0.003
  240. One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. Chest. 2014 Dec; 146(6):1531-1542.
    View in: PubMed
    Score: 0.003
  241. A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation. Respir Med. 2014 Sep; 108(9):1310-20.
    View in: PubMed
    Score: 0.003
  242. Omalizumab in asthma: an update on recent developments. J Allergy Clin Immunol Pract. 2014 Sep-Oct; 2(5):525-36.e1.
    View in: PubMed
    Score: 0.003
  243. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem. 2014 May 02; 289(18):12623-32.
    View in: PubMed
    Score: 0.003
  244. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest. 1994 Jan; 105(1):111-6.
    View in: PubMed
    Score: 0.003
  245. Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol. 2013 Dec; 132(6):1295-302.
    View in: PubMed
    Score: 0.003
  246. Tuberculosis presenting with generalized lymphadenopathy, pulmonary infiltrates, and bone destruction in a young man. Arch Intern Med. 1993 May 24; 153(10):1265-7.
    View in: PubMed
    Score: 0.003
  247. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. Lancet Respir Med. 2013 May; 1(3):210-23.
    View in: PubMed
    Score: 0.003
  248. Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD. 2013 Aug; 10(4):482-92.
    View in: PubMed
    Score: 0.003
  249. Comparative effectiveness of noninvasive ventilation vs invasive mechanical ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure. J Hosp Med. 2013 Apr; 8(4):165-72.
    View in: PubMed
    Score: 0.003
  250. Age-related differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol. 2013 Apr; 110(4):240-6, 246.e1.
    View in: PubMed
    Score: 0.003
  251. Racial differences in CT phenotypes in COPD. COPD. 2013 Feb; 10(1):20-7.
    View in: PubMed
    Score: 0.003
  252. The safety of long-acting ?2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013; 8:53-64.
    View in: PubMed
    Score: 0.003
  253. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012 Aug 23; 10:100.
    View in: PubMed
    Score: 0.003
  254. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012 Apr; 9(2):151-9.
    View in: PubMed
    Score: 0.003
  255. Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol. 2012 May; 129(5):1252-1258.e1.
    View in: PubMed
    Score: 0.003
  256. Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J Appl Physiol (1985). 2012 Jan; 112(1):42-7.
    View in: PubMed
    Score: 0.003
  257. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011 Sep 22; 365(12):1088-98.
    View in: PubMed
    Score: 0.003
  258. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug 02; 155(3):179-91.
    View in: PubMed
    Score: 0.003
  259. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011 Oct; 261(1):274-82.
    View in: PubMed
    Score: 0.003
  260. Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD. 2011 Aug; 8(4):285-92.
    View in: PubMed
    Score: 0.003
  261. Racial differences in quality of life in patients with COPD. Chest. 2011 Nov; 140(5):1169-1176.
    View in: PubMed
    Score: 0.003
  262. Measuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care. Int J Chron Obstruct Pulmon Dis. 2011; 6:297-307.
    View in: PubMed
    Score: 0.003
  263. Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease. Metabolism. 2011 Oct; 60(10):1449-55.
    View in: PubMed
    Score: 0.003
  264. New perspectives regarding ?(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol. 2011 May; 163(1):18-28.
    View in: PubMed
    Score: 0.003
  265. Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc. 2011 May; 86(5):375-81.
    View in: PubMed
    Score: 0.003
  266. Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol. 2011 Jul; 107(1):65-70.
    View in: PubMed
    Score: 0.003
  267. beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010 Jun; 10(3):254-9.
    View in: PubMed
    Score: 0.002
  268. Arformoterol tartrate in the treatment of COPD. Expert Rev Respir Med. 2010 Apr; 4(2):155-62.
    View in: PubMed
    Score: 0.002
  269. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18; 5:1-10.
    View in: PubMed
    Score: 0.002
  270. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther. 2009 Nov; 26(11):1024-34.
    View in: PubMed
    Score: 0.002
  271. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009 Dec 01; 6(7):573-80.
    View in: PubMed
    Score: 0.002
  272. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009 Sep; 18(3):198-207.
    View in: PubMed
    Score: 0.002
  273. Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A. 2009 Feb 17; 106(7):2435-40.
    View in: PubMed
    Score: 0.002
  274. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 Oct; 134(4 Suppl):43S-56S.
    View in: PubMed
    Score: 0.002
  275. Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial. Ther Adv Respir Dis. 2008 Aug; 2(4):199-208.
    View in: PubMed
    Score: 0.002
  276. It's about time--directing our attention toward modifying the course of COPD. Respir Med. 2008 Jun; 102 Suppl 1:S37-48.
    View in: PubMed
    Score: 0.002
  277. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008 May 01; 5(4):475-7.
    View in: PubMed
    Score: 0.002
  278. Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Ther Adv Respir Dis. 2008 Apr; 2(2):37-48.
    View in: PubMed
    Score: 0.002
  279. Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. COPD. 2008 Feb; 5(1):25-34.
    View in: PubMed
    Score: 0.002
  280. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. Clin Ther. 2008; 30 Spec No:989-1002.
    View in: PubMed
    Score: 0.002
  281. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther. 2007 Feb; 29(2):261-78.
    View in: PubMed
    Score: 0.002
  282. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol. 2006 Dec; 118(6):1226-33.
    View in: PubMed
    Score: 0.002
  283. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):254-61.
    View in: PubMed
    Score: 0.002
  284. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med. 2006 May; 24(3):259-67.
    View in: PubMed
    Score: 0.002
  285. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May; 27(5):531-42.
    View in: PubMed
    Score: 0.002
  286. Pulmonary-renal syndromes in the intensive care unit. Crit Care Clin. 2002 Oct; 18(4):881-95, x.
    View in: PubMed
    Score: 0.001
  287. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma. 2002 Feb; 43(2):423-6.
    View in: PubMed
    Score: 0.001
  288. Ventilation of patients with asthma and obstructive lung disease. Crit Care Clin. 1998 Oct; 14(4):685-705.
    View in: PubMed
    Score: 0.001
  289. The accuracy of a handheld portable spirometer. Chest. 1996 Jan; 109(1):152-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.